A

Aptevo Therapeutics

D
APVO
USD
0.0428
(16.5891%)
Market Closed
90,684.00
حجم التداول
-12.52
الربح لكل سهم
-
العائد الربحي
-0.008950
P/E
4,043,105.14
حجم السوق
اليوم
16.5891%
1 اسبوع
11.407%
1 شهر
83.863%
6 اشهر
-74.291%
12 اشهر
-96.938%
بداية السنة
-96.301%
كل الوقت
0%

Title:
Aptevo Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
هل تحتاج مساعدة او لديك استفسار؟